Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

CB Scientific Inc

Healthcare US CBSC

0.04USD
0.0002(0.50%)

Last update at 2026-06-02T20:00:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.020.06
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap6.62M
  • Volume9200
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.71635M
  • Revenue TTM0.05M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.03M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -1.68070M -1.63024M -2.10658M -6.34228M -4.32768M
Minority interest - - - - -
Net income -1.68070M -1.63024M -2.10658M -6.34228M -4.32768M
Selling general administrative 1.20M 1.31M 2.14M 1.80M 2.96M
Selling and marketing expenses - - - - -
Gross profit 0.04M 0.14M 0.04M -0.07366M 0.02M
Reconciled depreciation - - 0.00000M 0.00061M 0.00675M
Ebit - -1.59570M - - -
Ebitda -1.69403M -1.62495M -2.10137M -4.79785M -3.97663M
Depreciation and amortization - -0.02925M - - -
Non operating income net other - - - - -
Operating income -1.32779M -1.59570M -2.10191M -1.87082M -2.94261M
Other operating expenses 1.37M 1.73M - - -
Interest expense 0.22M 0.00529M 0.00521M 1.54M 0.34M
Tax provision - - - - -
Interest income - 0.00000M 0.00054M - -
Net interest income -0.22243M -0.00529M -0.00466M -1.54381M -0.34430M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.04M 0.14M 0.08M 0.08M 0.03M
Total operating expenses 1.37M 1.73M 2.18M 1.95M 2.98M
Cost of revenue 0.00000M 0.00000M 0.04M 0.15M 0.00981M
Total other income expense net -0.35291M -0.03454M - -2.92764M -1.04077M
Discontinued operations - - - - -
Net income from continuing ops -1.91646M -1.63024M -2.10658M -6.34228M -4.32768M
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 0.17M 0.30M 0.30M 0.65M 0.31M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.00803M 0.02M - - -
Total liab 2.12M 0.94M 0.68M 0.16M 0.50M
Total stockholder equity -1.95710M -0.64281M -0.37686M 0.49M -0.18988M
Deferred long term liab - - - - -
Other current liab 1.55M 0.61M - - -
Common stock 0.16M 0.15M - - -
Capital stock 0.16M 0.16M 0.13M 0.11M 0.08M
Retained earnings -18.01064M -16.32994M -14.69970M -12.63696M -6.29468M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.05M 0.13M 0.14M 0.43M 0.02M
Cash and equivalents - - - - -
Total current liabilities 2.02M 0.83M 0.68M 0.16M 0.50M
Current deferred revenue 0.13M 0.17M - - -
Net debt 0.21M -0.10510M - - 0.37M
Short term debt 0.26M 0.02M - - -
Short long term debt 0.26M 0.02M 0.10M 0.04M 0.38M
Short long term debt total 0.26M 0.02M - - -
Other stockholder equity 15.89M 15.53M - - -
Property plant equipment - - - - -
Total current assets 0.09M 0.18M 0.18M 0.65M 0.31M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 0.00651M 0.00468M 0.00385M 0.05M 0.01M
Long term debt - - - - 0.00510M
Inventory 0.03M 0.03M 0.02M 0.00927M 0.15M
Accounts payable 0.07M 0.03M 0.02M 0.00977M 0.00921M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.00200M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.07M 0.12M - - -
Deferred long term asset charges - - - - -
Non current assets total 0.07M 0.12M 0.12M 0.00000M 0.00061M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments - 0.00000M 0.04M -0.04000M -0.12500M
Change to liabilities - - - - -
Total cashflows from investing activities - - - - -
Net borrowings - 0.00000M - - -
Total cash from financing activities - 1.24M 0.86M 1.23M 0.79M
Change to operating activities - - - - -
Net income -1.68070M -1.63024M -2.10658M -6.34228M -4.32768M
Change in cash - -0.01042M -0.29052M 0.41M 0.00375M
Begin period cash flow 0.13M 0.14M 0.43M 0.02M 0.01M
End period cash flow - 0.13M 0.14M 0.43M 0.02M
Total cash from operating activities - -1.24542M -1.18700M -0.78603M -0.66259M
Issuance of capital stock - 1.24M 0.25M - -
Depreciation - - 0.00000M 0.00061M 0.00675M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - -0.00450M -0.01412M 0.02M 0.00000M
Change to account receivables - -0.00084M - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 0.35M 0.48M 0.18M 0.21M
Stock based compensation - 0.00980M 0.10M - -
Other non cash items - 0.03M 0.34M 2.30M 3.44M
Free cash flow - -1.24542M -1.18700M -0.78603M -0.66259M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBSC
CB Scientific Inc		 0.0002 0.50% 0.04 - - 131.38 275.45 92.85 -10.2022
ISRG
Intuitive Surgical Inc		 4.99 1.24% 407.29 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 - -% 196.12 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -0.98 0.99% 98.17 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 1.18 0.82% 145.61 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Cardiac Biotech Solutions Inc. in May 2025. The company is based in Las Vegas, Nevada.

CB Scientific Inc

10845 Griffith Peak Drive, Las Vegas, NV, United States, 89135

Key Executives

Name Title Year Born
Mr. Charles K. Martin III Pres, CEO & Director 1956
Ms. Brooke Martellaro Chief Financial Officer NA
Mr. James Ott CTO & Director NA
Mr. Charles K. Martin III President, CEO & Director 1956
Mr. William Griffin Thomas CPA CFO & Treasurer 1976
Mr. Charles K. Martin III President, CEO & Director 1957

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.